Dyne Therapeutics (DYN) Current Leases (2021 - 2026)
Dyne Therapeutics' (DYN) quarterly Current Leases came in at $5.0 million in Q1 2026, down 1.53% year-on-year from $5.1 million in Q1 2025, and up 0.76% on a QoQ basis from $5.0 million in Q4 2025.
Dyne Therapeutics (DYN) Current Leases (2021 - 2026) Analysis & Trends
Dyne Therapeutics (DYN) has 6 years of Current Leases data on file, last reported at $5.0 million in Q1 2026.
- On a quarterly basis, Current Leases fell 1.53% year-over-year to $5.0 million in Q1 2026; TTM through Mar 2026 was $5.0 million, a 1.53% decrease from a year earlier, with the FY2025 full-year figure at $5.0 million, up 2.99% from the prior year.
- Current Leases for Q1 2026 stood at $5.0 million, up from $5.0 million in the prior quarter.
- Over the last five years, Current Leases for DYN reached as high as $5.5 million in Q2 2022 and fell as low as $4.6 million in Q3 2022.
- Historically, Current Leases has averaged $4.9 million across 5 years, with a median of $4.8 million in 2024.
- Across the five-year window, Current Leases gained 18.42% in 2022 and decreased 14.14% in 2023, its largest moves.
- Year by year, Current Leases stood at $4.6 million in 2022, then advanced by 2.39% to $4.7 million in 2023, then grew by 2.75% to $4.8 million in 2024, then climbed by 2.99% to $5.0 million in 2025, then advanced by 0.76% to $5.0 million in 2026.
- Per Business Quant data, the three most recent Current Leases figures were $5.0 million in Q1 2026, $5.0 million in Q4 2025, and $5.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 20.58 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 872,589.03 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.61 Mn |
| 10 | Dyne Therapeutics | 3.94 Bn | 3.94 Bn | - | 5.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.03 Mn |
| Dec 31, 2025 | 5.00 Mn |
| Sep 30, 2025 | 5.04 Mn |
| Jun 30, 2025 | 5.00 Mn |
| Mar 31, 2025 | 5.11 Mn |
| Dec 31, 2024 | 4.85 Mn |
| Sep 30, 2024 | 4.81 Mn |
| Jun 30, 2024 | 4.78 Mn |
| Mar 31, 2024 | 4.76 Mn |
| Dec 31, 2023 | 4.72 Mn |
| Sep 30, 2023 | 4.71 Mn |
| Jun 30, 2023 | 4.71 Mn |
| Mar 31, 2023 | 4.64 Mn |
| Dec 31, 2022 | 4.61 Mn |
| Sep 30, 2022 | 4.58 Mn |
| Jun 30, 2022 | 5.49 Mn |
| Mar 31, 2022 | 4.71 Mn |
| Dec 31, 2021 | 3.89 Mn |
| Sep 30, 2021 | 4.59 Mn |